Podcast

Achieving High Yield, Versatility, and Scalability for Adherent Cell Culture with Circulation/Perfusion Systems Podcast

Author(s):

Corning Life Sciences

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Related Content
Ribosome translating mRNA into a polypeptide chain | Image Credit: © Juan Gärtner - © Juan Gärtner - stock.adobe.com
September 4th 2025

Quotient Sciences and CPI Target Faster RNA-Based Drug Development

Feliza Mirasol
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
September 4th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Silver Spring, MD, USA - June 25, 2022: Closeup of the FDA sign seen at its headquarters campus in Silver Spring, Maryland. FDA is a federal agency of the Department of Health and Human Services | Image Credit: © Tada Images - stock.adobe.com.
September 4th 2025

Biopharma Impacts of Paul Offit's Ousting from FDA Vaccine Panel

Christopher Cole
Mastering Antibody-Drug Conjugates
September 4th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
David Cali is senior director of Security & DEA Compliance at Reworld.
September 4th 2025

Best Practices for Secure Disposal of Controlled Substance Pharmaceuticals

David Cali
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
September 4th 2025

MS Pharma and Polpharma Biologics Partner to Expand Biosimilar Access in MENA

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.